India’s first indigenously produced CAR-T cell therapy – NexCAR19 receives CDSCO approval
Immunoadoptive Cell Therapy Private Limited (ImmunoACT), an IIT Bombay spin-off, backed by Hyderabad-based leading pharmaceutical and biotechnology multinational company (Laurus Labs) received the CDSCO approval